• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.71% Nasdaq Up0.61%

    Cogentix Medical, Inc. (UPI)

    1.20 Down 0.05(4.00%) Mar 31 - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Cogentix Medical, Inc.
    5420 Feltl Road
    Minnetonka, MN 55343
    United States - Map
    Phone: 952-426-6140
    Website: http://www.cogentixmedical.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:211

    Business Summary 

    Cogentix Medical, Inc., a medical device company, designs, develops, manufactures, and markets products for the urology market and flexible endoscopy. The company offers Urgent PC neuromodulation system for the overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. It also provides EndoSheath system, which combines endoscopic technology with a sterile and disposable microbial barrier for flexible endoscopy. The company operates primarily in the United States, the Netherlands, and the United Kingdom. It primarily serves physicians. Cogentix Medical, Inc. was founded in 1987 and is headquartered in Minnetonka, Minnesota.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Cogentix Medical, Inc.

    Key Executives 
    Mr. Robert C.E. Kill , 51
    Chairman, Chief Exec. Officer and Pres
    Mr. Brett A. Reynolds Buché, 46
    Chief Financial Officer, Sr. VP and Sec.
    Mr. Darin Hammers , 50
    Sr. VP of Global Sales and Marketing
    Mr. Daniel P. Merz , 37
    VP of Operations and Regulatory Affairs
    Mr. Larry Heinemann , 63
    VP of Corp. Devel.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in .
    View Insiders